A Prospective, Multicenter Study of Complementary/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer
Creators
- 1. Department of Radiation Therapy, William W. Backus Hospital, Norwich, Connecticut (United States)
- 2. Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut (United States)
- 3. Department of Epidemiology and Public Health, Yale University, New Haven, Connecticut (United States)
- 4. University of Michigan, Department of Radiation Oncology, Ann Arbor, MI (United States)
- 5. Yale University School of Medicine, New Haven, Connecticut (United States)
- 6. Department of Radiation Therapy, Shoreline Medical Center, Guilford, Connecticut (United States)
- 7. Department of Radiation Therapy, Lawrence and Memorial Hospital, New London, Connecticut (United States)
Description
Purpose: Although complementary and alternative medicine (CAM) utilization in breast cancer patients is reported to be high, there are few data on CAM practices in breast patients specifically during radiation. This prospective, multi-institutional study was conducted to define CAM utilization in breast cancer during definitive radiation. Materials/Methods: A validated CAM instrument with a self-skin assessment was administered to 360 Stage 0-III breast cancer patients from 5 centers during the last week of radiation. All data were analyzed to detect significant differences between users/nonusers. Results: CAM usage was reported in 54% of the study cohort (n=194/360). Of CAM users, 71% reported activity-based CAM (eg, Reiki, meditation), 26% topical CAM, and 45% oral CAM. Only 16% received advice/counseling from naturopathic/homeopathic/medical professionals before initiating CAM. CAM use significantly correlated with higher education level (P<.001), inversely correlated with concomitant hormone/radiation therapy use (P=.010), with a trend toward greater use in younger patients (P=.066). On multivariate analysis, level of education (OR: 6.821, 95% CI: 2.307-20.168, P<.001) and hormones/radiation therapy (OR: 0.573, 95% CI: 0.347-0.949, P=.031) independently predicted for CAM use. Significantly lower skin toxicity scores were reported in CAM users vs nonusers, respectively (mild: 34% vs 25%, severe: 17% vs 29%, P=.017). Conclusion: This is the first prospective study to assess CAM practices in breast patients during radiation, with definition of these practices as the first step for future investigation of CAM/radiation interactions. These results should alert radiation oncologists that a large percentage of breast cancer patients use CAM during radiation without disclosure or consideration for potential interactions, and should encourage increased awareness, communication, and documentation of CAM practices in patients undergoing radiation treatment for breast cancer.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2012.03.025Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2012.03.025;
- PII
- S0360-3016(12)00420-8;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 85
- Journal Issue
- 1
- Journal Page Range
- p. 40-46
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 44104372
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COMMUNICATIONS; EDUCATION; HORMONES; INTERACTIONS; MAMMARY GLANDS; MEDICAL PERSONNEL; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENTS; RADIOTHERAPY; SKIN; TOXICITY
- Descriptors DEC
- BODY; DISEASES; GLANDS; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PERSONNEL; RADIOLOGY; STATISTICS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.